What is the point of large-scale collections of human induced pluripotent stem cells?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

35 citing papers in PubMed.

1. Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy.International journal of molecular sciences · 2023
   Review
2. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.Stem cell research & therapy · 2021
   Article
3. Human neuronal signaling and communication assays to assess functional neurotoxicity.Archives of toxicology · 2021
   Article
4. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.Journal of biomedical science · 2020
   Article
5. Derivation of Intestinal Organoids from Human Induced Pluripotent Stem Cells for Use as an Infection System.Methods in molecular biology (Clifton, N.J.) · 2019
   Article
6. Corneal cell therapy: with iPSCs, it is no more a far-sight.Stem cell research & therapy · 2018
   Review
7. Interleukin-22 promotes phagolysosomal fusion to induce protection againstProceedings of the National Academy of Sciences of the United States of America · 2018
   Article
8. Stem Cell Pathology.Annual review of pathology · 2018
   Review
9. A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells.Stem cell reports · 2018
   Review
10. Humanity in a Dish: Population Genetics with iPSCs.Trends in cell biology · 2018
    Review
11. Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells.Frontiers in pediatrics · 2018
    Review
12. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.Stem cell reports · 2017
    Article
13. The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.Regenerative medicine · 2017
    Article
14. Understanding the genetics behind complex human disease with large-scale iPSC collections.Genome biology · 2017
    Article
15. Small-molecule phenotypic screening with stem cells.Nature chemical biology · 2017
    Article
16. High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells.Stem cell reports · 2017
    Article
17. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.Stem cell reports · 2017
    Article
18. Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells.Cell stem cell · 2017
    Article
19. Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients.Frontiers in medicine · 2017
    Review
20. 21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine.JACC. Basic to translational science · 2016
    Article

Corrections and comments

• Erratum issued

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as